Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability
暂无分享,去创建一个
A. Mazurek | F. Pluciński | E. Kłosińska-Szmurło | M. Grudzień | K. Betlejewska-Kielak | J. Biernacka
[1] Hwanho Choi,et al. New solvation free energy function comprising intermolecular solvation and intramolecular self-solvation terms , 2013, Journal of Cheminformatics.
[2] I. Vattulainen,et al. Mechanism for translocation of fluoroquinolones across lipid membranes. , 2012, Biochimica et biophysica acta.
[3] A. Avdeef,et al. Predicting the exposure and antibacterial activity of fluoroquinolones based on physicochemical properties. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[4] Vilma Edite Fonseca Heinzen,et al. Estimating the Octanol/Water Partition Coefficient for Aliphatic Organic Compounds Using Semi-Empirical Electrotopological Index , 2011, International journal of molecular sciences.
[5] Z. Mutlu,et al. Oral toxicity of pefloxacin, norfloxacin, ofloxacin and ciprofloxacin: comparison of biomechanical and histopathological effects on Achilles tendon in rats. , 2011, The Journal of toxicological sciences.
[6] Lawrence X. Yu,et al. The BCS, BDDCS, and Regulatory Guidances , 2011, Pharmaceutical Research.
[7] L. Silver. Challenges of Antibacterial Discovery , 2011, Clinical Microbiology Reviews.
[8] A. Król,et al. The structure-bioavailability approach in antifungal agents. , 2009, European journal of medicinal chemistry.
[9] R. Mannhold,et al. Calculation of molecular lipophilicity: state of the art and comparison of methods on more than 96000 compounds , 2009, Journal of pharmaceutical sciences.
[10] A. Tsantili-Kakoulidou,et al. Electrostatic interactions and ionization effect in immobilized artificial membrane retention. A comparative study with octanol-water partitioning. , 2008, Journal of chromatography. A.
[11] H. Moser,et al. Physicochemical properties of antibacterial compounds: implications for drug discovery. , 2008, Journal of medicinal chemistry.
[12] M. Ruiz‐López,et al. Structure of levofloxacin in hydrophilic and hydrophobic media: Relationship to its antibacterial properties , 2007 .
[13] Peihua Qiu,et al. Generalized Least Squares , 2005, Technometrics.
[14] Hans H. Liu,et al. Appropriate antibiotic treatment of genitourinary infections in hospitalized patients. , 2005, The American journal of medicine.
[15] J. Maselli,et al. Antimicrobial Drug Prescribing for Pneumonia in Ambulatory Care , 2005, Emerging infectious diseases.
[16] M. Saux,et al. Protonation equilibrium and lipophilicity of moxifloxacin. , 2005, Journal of pharmaceutical and biomedical analysis.
[17] J. Hoogmartens,et al. Book Reviews : Who Expert Committee on Specifications for Pharmaceutical Preparations. Published by World Health Organisation, 1984. Price: Sw. fr. 6. Paperback. Pp 54. ISBN: 924 120704 3 , 1985, World Health Organization technical report series.
[18] H. Girault,et al. Theoretical and Experimental Exploration of the Lipophilicity of Zwitterionic Drugs in the 1,2-Dichloroethane/Water System , 2002, Pharmaceutical Research.
[19] Igor V. Tetko,et al. Application of Associative Neural Networks for Prediction of Lipophilicity in ALOGPS 2.1 Program , 2002, J. Chem. Inf. Comput. Sci..
[20] K. Morimoto,et al. Determination of lipophilicity of two quinolone antibacterials, ciprofloxacin and grepafloxacin, in the protonation equilibrium. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[21] Remigijus Didziapetris,et al. Fragmental Methods in the Design of New Compounds. Applications of The Advanced Algorithm Builder , 2002 .
[22] M. A. Cabrera Pérez,et al. A novel approach to determining physicochemical and absorption properties of 6-fluoroquinolone derivatives: experimental assessment. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[23] Y. Oh,et al. pH‐sensitive, serum‐stable and long‐circulating liposomes as a new drug delivery system , 2002, The Journal of pharmacy and pharmacology.
[24] Michael Levin. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System , 2001 .
[25] Igor V. Tetko,et al. Prediction of n-Octanol/Water Partition Coefficients from PHYSPROP Database Using Artificial Neural Networks and E-State Indices , 2001, J. Chem. Inf. Comput. Sci..
[26] M. Lösche,et al. Cooperativity of phospholipid reorganization upon interaction of dipyridamole with surface monolayers on water. , 2001, Biophysical chemistry.
[27] Glen Eugene Kellogg,et al. Very empirical treatment of solvation and entropy: a force field derived from Log Po/w , 2001, J. Comput. Aided Mol. Des..
[28] A. Petrauskas,et al. ACD/Log P method description , 2000 .
[29] Gordon M. Crippen,et al. Prediction of Physicochemical Parameters by Atomic Contributions , 1999, J. Chem. Inf. Comput. Sci..
[30] M. Bermejo,et al. Validation of a biophysical drug absorption model by the PATQSAR system. , 1999, Journal of pharmaceutical sciences.
[31] U. Holzgrabe,et al. Plasma protein binding of gyrase inhibitors. , 1998, Journal of pharmaceutical sciences.
[32] Y. Sugiyama,et al. Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs. , 1996, The Journal of pharmacology and experimental therapeutics.
[33] T. Halgren. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..
[34] C. Riley,et al. Physicochemical properties of the fluoroquinolone antimicrobials. III. 1-Octanol/water partition coefficients and their relationships to structure , 1992 .
[35] U. Jaehde,et al. Cerebrospinal fluid transport and disposition of the quinolones ciprofloxacin and pefloxacin in rats. , 1992, The Journal of pharmacology and experimental therapeutics.
[36] J. Pechère,et al. Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus , 1992, Antimicrobial Agents and Chemotherapy.
[37] Raimund Mannhold,et al. Calculation of Drug Lipophilicity: The Hydrophobic Fragmental Constant Approach , 1992 .
[38] W J Dunn,et al. The role of solvent-accessible surface area in determining partition coefficients. , 1987, Journal of medicinal chemistry.